Vineet Laboratories Ltd.

View in App
48.00 -0.37 ▼-0.8%

26 May 2023, 04:01:00 PM
Volume: 1,963

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vineetlabs.co.in
Market Cap 44.25 Cr.
Enterprise Value(EV) 74.34 Cr. 2022-12
Financial Indicators
Earnings per share (EPS) 1.07 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 44.97 Trailing Twelve Months Ending 2022-12
Industry PE 31.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 32.54 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.47 Calculated using Price: 48.00
Dividend Yield 2.08 Period Ending 2022-03
No. of Shares Subscribed 0.92 Cr. 9,219,008 Shares
FaceValue 10
About Vineet Laboratories Ltd.
The company is engaged in the business of Drug Intermediates & Bulk Dugs.

Vineet Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Vineet Laboratories Ltd. Performance

View details >>
1 Day
-0.76%
1 Week
+2.30%
1 Month
-1.05%
3 Month
-11.93%
6 Month
-18.85%
1 Year
-10.45%
2 Year
5 Year
10 Year

Vineet Laboratories Ltd. Fundamental Ratios

View details >>
5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -2.87 13.18 22.19
Return on Capital Employed (%) -2.87 34.06 23.30
Return on Assets (%) -2.72 3.26 5.48

Vineet Laboratories Ltd. Balance Sheet

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12* Rs. Cr.
Shh. Funds 0 0 0 27 33 30
Non Curr. Liab. 7 5 9
Curr. Liab. 0 0 75 95 72
Minority Int.
Equity & Liab. 0 0 0 109 134 111
Non Curr. Assets 22 31 28
Curr. Assets 0 0 0 86 103 83
Misc. Exp. not W/O 0 0
Total Assets 0 0 0 109 134 111

Vineet Laboratories Ltd. Profit and Loss

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 243 191 211
Other Income 0 0 0
Total Income 244 191 211
Total Expenditure 0 -235 -178 -203
PBIDT 0 9 14 8
Interest -3 -2 -4
Depreciation -2 -2 -2
Taxation -2 -3 -1
Exceptional Items
PAT 0 2 7 1
Adjusted EPS 0 2 7 1

Vineet Laboratories Ltd. Cash Flow

View details >>
Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 27 8
Cash Fr. Inv. -8 -4
Cash Fr. Finan. 19 14
Net Change 38 18
Cash & Cash Eqvt 38 56

Vineet Laboratories Ltd. Shareholding Pattern

View details >>
8 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 35.96 35.96 35.96 35.96 35.96 35.96 35.96 38.66
Public 64.04 64.04 64.04 64.04 64.04 64.04 64.04 61.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Vineet Laboratories Ltd. Announcements

View details >>
Wed, 24 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A(2) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are hereby enclosing the Secretarial Compliance Report issued by the Practising Company Secretary for the financial year ended on March 31 2023.
Thu, 18 May 2023
Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Monday May 29 2023. The purpose of the Board Meeting is - among other matters- to consider and approve the audited financial results of the Company for the 4th quarter and financial year ended on March 31 2023.
Thu, 20 Apr 2023
Submission Of Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.
The certificate ensuring all activities in relation to Share Transfer Facility are maintained by the Registrar to an issue and share transfer agent - Venture Capital and Corporate Investments Private Limited which is registered with SEBI under registration number: INR000001203.

Vineet Laboratories Ltd. Technical Scans

View details >>
Fri, 26 May 2023
High Delivery Percentage High Delivery Percentage
High Decrease in 3 Months High Decrease in 3 Months
CCI Crossed Above 100 CCI Crossed Above 100
CCI Overbought Zone CCI Overbought Zone
Thu, 25 May 2023
High Delivery Percentage High Delivery Percentage

Vineet Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Vineet Laboratories Ltd. FAQ's

What is Vineet Laboratories share price?
Can I buy Vineet Laboratories shares now?
What is the Dividend Yield of Vineet Laboratories?
What is the Market Cap of Vineet Laboratories?
What are the key metrics to analyse Vineet Laboratories?
What is the 52 Week High and Low of Vineet Laboratories?
What is the trend of Vineet Laboratories share price?